Company performance
Add to research
Current Price
as of Apr 17, 2025$0.35
P/E Ratio
N/A
Market Cap
$11.93M
Description
Add to research
Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests. The company was founded by Brent C. Satterfield and Dwight Howard Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.
Metrics
Add to research
Overview
- HQSalt Lake City, UT
- SectorHealth Technology
- IndustryBiotechnology
- TickerCODX
- Price$0.3474+3.09%
Trading Information
- Market cap$11.93M
- Float92.27%
- Average Daily Volume (1m)242,412
- Average Daily Volume (3m)192,235
- EPS-$1.24
Company
- Revenue$0.77M
- Rev growth (1yr)-22.33%
- Net income-$37.64M
- Gross margin-208.60%
- EBITDA margin-5,434.62%
- EBITDA-$41.85M
- EV-$4.84M
- EV/Revenue-6.29
- P/EN/A
- P/S13.99
- P/B0.22
- Debt/Equity3.96
Documents
Add to research
SEC Filings
Factset Street Account
Earnings Calls
Factset